Drugs with this side effect
- 1,25(OH)2D3
- 2-hydroxysuccinaldehyde: postmarketing
- 4-methylpyrazole
- 5-ASA: postmarketing, 11% - 23%
- 5-FU
- 5-aminolevulinic acid: 0% - 1%
- 5-aza-2'-deoxycytidine: 5.05% - 13.3%
- 5-azacytidine: 3.26% - 10.9%
- A77 1726: 1.96%
- AMD3100
- Abarelix: 30.9%
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- BCNU: 4% - 13.3%
- Bivalirudin: 2.4% - 16.6%
- CAS 1405-87-4
- CGP 19835A: very common, 15%
- Cancidas: 0% - 9%
- Carfilzomib: 0.19% - 12%
- EACA
- EDTA
- Enfuvirtide: 0% - 96%
- Eptifibatide: 1.2%
- FAMP: 20% - 22%
- FP-CIT: uncommon
- Fe(III: postmarketing, 0.7% - 10%
- Forteo: common, 21.3%
- Gd-DTPA
- Ge-132: postmarketing, 6% - 9%
- Glat copolymer
- Goserelin: 3% - 31%
- Histrelin
- Humalog: 10% - 19.8%
- ICI 182,780: postmarketing, 18.9% - 20.3%
- Implanon: postmarketing, 1% - 5.6%
- Insulin
- K779: 3% - 18%
- Kaluril
- LMWH
- LY146032: postmarketing
- Lantus
- Leuprorelin: postmarketing, 3% - 63%
- Lisinopril
- Lovaza: 1.8%
- Lutalyse
- Meropenem anhydrous: 5.1%
- Metrodin: postmarketing, 0% - 8.11%
- MnDPDP
- NovoLog
- Octreotide: 0.5% - 8-10%
- Oestrogen: 0.113% - 20%
- Optison
- PGE1: 1.03% - 1.5%
- PGE2
- Photofrin: 0% - 22%
- Photofrin II: uncommon, common
- Refludan
- Revasc
- SOM230
- SU5416
- SonoVue
- Stalevo 50
- Supremon: 4.6%
- T-A2-3
- Timentin
- Triptorelin: 2.1% - 3.4%
- UDCA
- VACV: 1% - 43%
- Vancocine: postmarketing
- abacavir: 3.61% - 7.41%
- acamprosate: 2% - 4%
- acebutolol
- acetate
- acitretin: postmarketing
- actinomycin D
- adapalene
- adenosine
- alendronate: 0.4% - 4.1%
- alfentanil
- alfuzosin: 1.48%
- allopurinol
- almotriptan: infrequent
- alosetron: infrequent, 5% - 7%
- amiloride
- amiodarone: postmarketing
- amlexanox: 7.09% - 8.31%
- amlodipine
- amlodipine besylate
- ammonia
- amphotericin B: 12.8% - 14%
- amsacrine
- anagrelide: 15%
- anastrozole: 10.7% - 17.2%
- anthracycline
- apraclonidine
- aprepitant
- argatroban: 3% - 9%
- aripiprazole: 2% - 3%
- arsenic
- arsenic trioxide: common
- articaine
- atazanavir
- atomoxetine
- atorvastatin
- atovaquone: 9.86% - 10%
- azelastine
- azithromycin: 4.4%
- aztreonam: 12%
- baclofen: common, 0% - 4%
- balsalazide
- beclomethasone: 1% - 5%
- beclomethasone dipropionate
- beclomethasone monopropionate: 1% - 5%
- bendamustine: postmarketing, 0%
- benzathine penicillin
- benzoyl: rare
- benzyl alcohol
- bepridil
- betaxolol
- bexarotene: very common, 12% - 40%
- bezafibrate: 1.1%
- bicalutamide: 27%
- biguanide
- bisoprolol: 2.1%
- bleomycin hydrochloride
- boceprevir: common, 4%
- bortezomib
- bosentan
- bosutinib
- brimonidine: 2.6% - 5.1%
- brinzolamide: 0.4% - 1.2%
- bromcresol green: 1% - 17%
- budesonide: postmarketing, 2.27% - 11.7%
- bupivacaine: 3.54% - 8%
- buprenorphine: 11.7% - 26.3%
- bupropion: postmarketing, rare, infrequent, 1.3% - 3%
- buspirone: 1%
- busulfan: 44%
- cabazitaxel: 1% - 2%
- cabergoline: 1.81% - 3.4%
- candesartan cilexetil
- capecitabine: 0.1% - 12%
- capreomycin
- carbamazepine: 12%
- carbidopa
- carboplatin: 23%
- carboprost
- carnitine: 21% - 35%
- carvedilol: 7.6% - 8.6%
- cefaclor: 0.667% - 2.04%
- cefazolin: postmarketing
- cefditoren
- cefepime
- cefotaxime
- cefoxitin
- cefpodoxime
- cefprozil: 1%
- ceftaroline
- ceftazidime: common
- ceftizoxime
- ceftobiprole
- ceftriaxone: 9.4%
- cefuroxime
- cetirizine
- cevimeline: 3.3%
- chlorambucil
- chlorhexidine
- ciclopirox
- cidofovir: 25.2%
- cilazapril
- cilostazol: postmarketing
- cinoxacin
- ciprofloxacin: postmarketing, uncommon
- cisplatin
- citalopram: infrequent, frequent, 1.3%
- cladribine: common, 6%
- clarithromycin: uncommon
- clindamycin
- clindamycin phosphate
- clobetasol: postmarketing
- clobetasol propionate
- clofarabine: common
- clomiphene citrate
- clomipramine: 3% - 4%
- clonazepam
- clopidogrel
- clozapine: 1%
- colesevelam: 5%
- colestimide: uncommon
- colestipol
- colestyramine: common
- conivaptan
- conjugated estrogens: postmarketing, 0.714% - 1.4%
- copolymer 1
- copper: 2.2% - 11.9%
- cortisol
- cyclizine
- cyclophosphamide: postmarketing
- cyproterone
- cytarabine: 0% - 20%
- cytokinin
- dacarbazine
- dalteparin: 1.34% - 1.54%
- dantrolene: postmarketing
- darifenacin
- darunavir
- dasatinib: common, 1% - 10%
- deferiprone
- deferoxamine: very common
- degarelix: 28%
- delavirdine
- deprenyl: 8%
- desmopressin: 0% - 2%
- desonide
- dexmedetomidine: postmarketing, 2%
- dexrazoxane: 0% - 13%
- diatrizoate
- diazepam
- diazoxide
- diclofenac: postmarketing, 0% - 30%
- dicloxacillin: rare, uncommon
- dicyclomine: postmarketing
- didanosine: postmarketing
- dihydroergotamine
- diltiazem: 0.99% - 6.33%
- dimercaprol
- dimercaptosuccinic acid
- dipyridamole: 2.6%
- disopyramide
- disulfiram
- docetaxel: postmarketing, uncommon, 0% - 2%
- dofetilide
- dolasetron: 0% - 3.08%
- donepezil: 3% - 9%
- dorzolamide
- doxazosin: 1.3% - 5.1%
- doxorubicin: postmarketing, common, 1.2% - 7.4%
- doxycycline: 1.5% - 23%
- doxycycline hyclate: 3.76%
- duloxetine: postmarketing, 4%
- ecallantide
- efavirenz: 1% - 17%
- eletriptan: frequent, 1% - 4%
- eliglustat
- emtricitabine: postmarketing, common
- entacapone: 6%
- ephedrine
- eplerenone
- eprosartan
- ergotamine
- eribulin
- erlotinib
- ertapenem
- erythromycin
- esmolol
- esomeprazole magnesium
- estazolam: 2%
- estradiol: postmarketing, 0% - 12.5%
- estradiol cypionate
- estradiol valerate
- estriol
- estrone
- ethacrynic acid
- etodolac
- etomidate
- etoposide
- etoposide phosphate
- everolimus: very common, 3.27% - 15.4%
- exemestane: common, 2.8% - 13%
- ezetimibe
- famotidine
- febuxostat
- felbamate: 6.5%
- fenofibrate: 1.43% - 3.47%
- fenofibric acid: 1.43% - 3.47%
- fentanyl: postmarketing
- ferumoxytol: postmarketing
- fexofenadine: 2.4%
- finasteride: 2.54%
- flecainide
- florbetaben
- fluconazole: uncommon
- fludarabine: 5% - 22%
- flumazenil
- flunisolide: 1.8% - 4.6%
- fluocinolone acetonide
- fluocinonide: postmarketing
- fluorescein: postmarketing, uncommon
- fluoxetine: 3% - 9%
- fluphenazine decanoate
- fluticasone: postmarketing, 2% - 4%
- fluticasone propionate
- fluvastatin
- fluvoxamine: infrequent, 4.4% - 10%
- fondaparinux: 1.7% - 2.55%
- formoterol: 8%
- fosaprepitant dimeglumine
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril
- fosinoprilat
- fotemustine: common
- frovatriptan: frequent
- furosemide
- fusidic acid
- gabapentin: postmarketing, rare, 1.1% - 30%
- gadobenate dimeglumine: postmarketing
- gadobutrol
- gadodiamide
- gadofosveset
- gadolinium: postmarketing, 0.4% - 1.83%
- gadopentetate
- gadoteridol
- gadoversetamide: 0.481% - 3.95%
- gamma-aminobutyric acid
- ganciclovir: 2.5% - 4.6%
- gefitinib: rare, 0.877% - 16%
- gemcitabine: 1%
- gemfibrozil: 1.5%
- gemifloxacin
- gliclazide
- glipizide
- glucose
- glucose solution
- glutamine: 6.25% - 18.8%
- glycerol
- glycine
- glycopyrrolate
- gonadorelin: 2.54% - 6.98%
- granisetron: 8% - 10.1%
- heparin: postmarketing
- hepatitis B vaccines: very common
- histamine
- hydromorphone: 2.34%
- hydroxocobalamin
- hydroxybutyrate: 1% - 20%
- hydroxychloroquine
- hydroxyurea
- ibandronate
- icodextrin
- ifosfamide: postmarketing
- iloprost
- imatinib: 0.7% - 45.5%
- imiquimod: uncommon, 0% - 8%
- indapamide: 8%
- indinavir
- indomethacin
- insulin detemir: 0.9% - 1.2%
- iodide
- iodixanol
- iohexol: 26%
- iopamidol: 2.8%
- iopromide: postmarketing, 0.1%
- iotrolan
- ioversol
- ioxaglate
- ioxilan
- ipratropium bromide: postmarketing, 0.9% - 4.1%
- irbesartan: rare
- irbesartan-hydrochlorothiazide
- irinotecan: 2% - 61.5%
- isomannide
- isopropyl unoprostone
- isosorbide-5-mononitrate
- itraconazole: 0% - 4%
- ivermectin
- ixabepilone: 0% - 9%
- kanamycin
- ketamine
- ketoconazole: postmarketing
- labetalol: 3.5%
- lamivudine: 2% - 22.1%
- lamotrigine: frequent, 0% - 6.2%
- lanreotide: 8.82% - 21.6%
- lansoprazole: 1.61% - 2.3%
- lasofoxifene
- latanoprost
- leflunomide: 1% - 5%
- lenalidomide: postmarketing, uncommon
- letrozole: 5% - 7%
- leuprorelin acetate: 2.3% - 32.7%
- levetiracetam: 6% - 7%
- levodopa/carbidopa
- levonorgestrel: 4.9%
- lincomycin
- lindane: postmarketing
- lithium carbonate
- loratadine
- lorazepam
- losartan: 1% - 2%
- loteprednol etabonate
- lovastatin
- lubiprostone: 2% - 3%
- mTHPC: very common
- mafenide acetate
- malvidin: 2.6% - 5.1%
- mannitol
- maraviroc: 3% - 4%
- megestrol: 0% - 6%
- megestrol acetate
- melatonin
- meloxicam: 0.9% - 5.2%
- melphalan
- memantine: 2.07% - 3%
- meropenem: 5.1%
- mesna: postmarketing, 7.6% - 10%
- metaproterenol: 0.2% - 1%
- methocarbamol
- methotrexate
- methyl aminolevulinate: postmarketing, 0% - 86.5%
- methylnaltrexone
- methylphenidate: postmarketing, 1.2% - 1.7%
- methysergide
- metolazone
- metoprolol
- metronidazole
- metyrapone
- mexiletine: 1.7% - 2.9%
- miconazole: 0.7% - 2.8%
- midazolam: 3.7%
- midodrine: 0% - 4.9%
- mifepristone: 14%
- miglustat: 0% - 8%
- minocycline: 1.2% - 5%
- mipomersen: 56%
- mirtazapine
- misoprostol: postmarketing
- mitomycin C
- mitotane
- mitoxantrone: 8-41%
- modafinil: 1%
- moexiprilat
- mometasone
- mometasone furoate
- monoethanolamine: 1.6%
- montelukast: 1.7% - 2.9%
- morphine: postmarketing, 3%
- moxifloxacin
- moxonidine
- mupirocin
- mycophenolate mofetil: 1.8% - 77.7%
- mycophenolic acid: 8.6% - 77.7%
- nabilone
- nafcillin
- naftifine: postmarketing
- naltrexone
- naproxen: 3-9%
- naratriptan: infrequent, common, 2% - 4%
- nefazodone
- nelarabine: 0% - 11%
- nelfinavir: 0% - 5.13%
- niacin
- nicardipine: 0.6%
- nicorandil: uncommon
- nicotine: 2.1%
- nifedipine: 2.7%
- nilotinib: uncommon, common
- nilutamide
- nitazoxanide
- nizatidine: 2.7% - 4.2%
- nystatin
- ofatumumab
- ofloxacin
- ogen
- olanzapine: 0% - 10%
- olmesartan: common, 0.568% - 1.54%
- olmesartan medoxomil
- olopatadine
- omeprazole: postmarketing
- ondansetron: postmarketing, 2.19%
- orlistat: uncommon, 10.8%
- oseltamivir: postmarketing
- oxaliplatin: very common, 1% - 14%
- oxcarbazepine
- oxiconazole
- oxybutynin: 1%
- paclitaxel: common, very common
- paliperidone
- palonosetron: postmarketing
- pamidronate: common, 0% - 15%
- pantoprazole: 1%
- paricalcitol: 3.7% - 4%
- paroxetine: common, frequent, 3%
- pazopanib
- pemetrexed
- penbutolol: 0.4% - 2.4%
- penciclovir: postmarketing, 0%
- penicillin
- pentamidine
- pentostatin: 8% - 20%
- pergolide: frequent, 7%
- perindopril
- perindopril erbumine
- phencyclidine
- phenobarbital
- phentolamine
- phosphate
- pilocarpine: 4%
- pimecrolimus
- piperacillin
- piroxicam
- podophyllotoxin: 11.5% - 72%
- polymyxin B
- pomalidomide: 4.46% - 5.61%
- ponatinib: 0% - 16%
- posaconazole: 0.718% - 11.3%
- potassium
- potassium phosphate
- pralidoxime
- pramipexole: 1.4%
- pravastatin
- prazosin
- prednicarbate
- pregabalin: 3.3% - 5%
- prilocaine
- probenecid
- procarbazine
- progesterone: 7% - 28.5%
- promethazine
- propafenone: 0% - 1%
- propofol
- prostacyclin: 65% - 84%
- quetiapine: 1% - 7%
- quinidine: 6% - 14%
- rabeprazole
- radium
- raloxifene: common
- raltegravir
- raltitrexed: 2-3%
- ranitidine
- rapamycin: 20% - 33%
- rasburicase
- regadenoson: postmarketing
- regorafenib
- remifentanil: 1.26% - 17.5%
- rescinnamine: 1.4%
- retapamulin
- retinoic acid: postmarketing, very common, 0% - 37%
- ribavirin: common, 9% - 13%
- rifabutin: 1%
- rifampicin
- rifapentine
- rifaximin
- riluzole
- risedronate: 7.7% - 9.9%
- risperidone: 1% - 10%
- ritonavir: 0.8% - 2.2%
- rivaroxaban
- rivastigmine: infrequent, frequent
- rizatriptan: 1% - 9%
- ropinirole: infrequent, 5% - 8%
- ropivacaine: 0.9% - 16.8%
- rosuvastatin
- rotigotine
- salbutamol: 1.4% - 6.7%
- salmeterol
- salmon calcitonin acetate: uncommon
- samarium: 7.04%
- saquinavir
- scopolamine
- sertraline: 1% - 6%
- sevelamer
- sevelamer hydrochloride
- sevoflurane
- sibutramine
- sildenafil
- simvastatin
- sitagliptin
- sitaxsentan
- sodium cromoglycate
- sodium ferric gluconate: 0.7% - 10%
- sodium tetradecyl sulphate
- sofosbuvir: very common
- sorafenib: postmarketing, very common, 0% - 31%
- sotalol: 2.5% - 4.1%
- stavudine
- streptozotocin
- strontium ranelate: postmarketing
- sugammadex
- sumatriptan: postmarketing, infrequent, common, 1% - 8%
- sunitinib
- suprofen
- tacrolimus: common, 0% - 63%
- tadalafil
- tamoxifen: 0% - 17.2%
- tamsulosin: 7.6%
- tazarotene
- technetium-99m
- tegaserod
- telavancin: uncommon
- telmisartan: postmarketing, rare, 3.5%
- temozolomide: uncommon, common, 1% - 3%
- temsirolimus: postmarketing
- tenofovir: 7% - 12%
- tenofovir disoproxil fumarate: 7% - 12%
- terazosin: 3.5%
- terbinafine: 0.1% - 1%
- terconazole: 2.1%
- tesamorelin: 1.7%
- testosterone: uncommon
- testosterone propionate
- testosterone undecanoate
- tetrofosmin: 1%
- thalidomide: 0% - 64.7%
- thiotepa
- thymidine
- tiagabine: 2% - 7%
- ticlopidine
- tigecycline: 2.9% - 3.7%
- tiludronate
- timolol
- tipranavir
- tirofiban: 2% - 5%
- tobramycin: very common, 8.1%
- tolcapone: infrequent
- tolterodine
- topiramate: 2.9% - 6.2%
- topotecan: 1% - 50%
- torasemide
- toremifene
- tramadol: postmarketing, uncommon
- tranylcypromine
- travoprost: 0.3% - 3.5%
- trazodone: 5.1% - 5.6%
- treprostinil
- triamcinolone
- triamcinolone acetonide: 4.7%
- triazolam
- trovafloxacin
- unoprostone
- ustekinumab
- v 1784: postmarketing, 3.2% - 15.6%
- valdecoxib
- valganciclovir: 3% - 7%
- valproate: common, 1% - 23%
- vandetanib
- vardenafil
- varenicline
- venlafaxine
- verapamil: 2.4%
- verteporfin: uncommon
- vigabatrin
- vinblastine
- vincristine: 8.43%
- vinflunine
- vinorelbine
- vismodegib
- vitamin K
- voriconazole
- warfarin
- zafirlukast: 1.9%
- zalcitabine
- zaleplon: infrequent
- zanamivir: 8% - 19%
- ziconotide
- zidovudine: uncommon
- zidovudine/lamivudine: 4.1% - 14%
- zileuton
- zoledronic acid: uncommon, common, very common, 1.5% - 24.2%
- zolmitriptan: 1% - 26%
- zolpidem: rare
- zopiclone: infrequent, 4% - 5%
- zuclopenthixol
|
Drugs with this indication
|
